Skip to main content

Table 1 Demographics and patient characteristics

From: Outcomes of cytomegalovirus retinitis-related retinal detachment surgery in acquired immunodeficiency syndrome patients in an Asian population

Race, n (%)

 

  Chinese

14 (73.7)

  Malay

3 (15.8)

  Others

2 (10.5)

Gender, n (%)

 

  Male

16 (84.2)

  Female

3 (15.8)

HAART use during RD, n (%)

 

  Yes

18 (94.7)

  No

1 (5.3)

Intravitreal Ganciclovir use, n (%)

 

  Yes

18 (94.7)

  No

1 (5.3)

IRU before retinal detachment, n (%)

 

  Yes

7 (36.8)

  No

12 (63.2)

Mean age, years (SD)

 

  HIV diagnosis

40.6 (7.34)

  Retinal reattachment surgery

45.6 (9.35)

Median CD4 counts, cells /μL [Range]

 

  HIV diagnosis

97.0 [2 - 830]

  CMV retinitis diagnosis

53.0 [6 - 410]

  Retinal detachment (RD)

91.5 [15 - 571]

    Active CMVR at RD (n = 5)

67.0 [20 - 247]

    Inactive CMVR at RD (n = 13)

93.0 [15 - 571]

Median intervals, months [Range]

 

  HIV to RD

16.5 [3 - 210]

  CMV retinitis to RD

2.7 [0 - 121]

  HIV to commencement of HAART

14.6 [0 - 217]

  Commencement of HAART to RD

9.0 [-1 - 112]

  Immune recovery uveitis to RD

1.0 [0 - 12]

  1. Received oral valganciclovir.
  2. HAART: highly active anti-retroviral therapy, RD: retinal detachment, IRU: immune recovery uveitis, HIV: Human immunodeficiency virus, CMVR: cytomegalovirus retinitis.